Managed Healthcare Executive April 9, 2024
The recent collaboration between The Innovation and Value Initiative (IVI), Alliance for Aging Research, Leavitt Partners, LLC, and National Pharmaceutical Council (NPC) has shed light on critical health equity issues and patient engagement within the Drug Price Negotiation Program (DPNP) context.
In December 2023, the IVI, Alliance for Aging Research, Leavitt Partners, LLC, and National Pharmaceutical Council (NPC) convened a half-day symposium discussing, ‘Ensuring Equity in Implementation of IRA Drug Price Negotiations.’
The symposium included a diverse range of stakeholders, including policy professionals, agency staff, patient communities, and other subject-matter experts, who discussed implementation of the DPNP through a patient-centered equity lens. The DPNP, established by the Centers for Medicare and Medicaid Services (CMS) under the remit of the Inflation...
Today's Sponsors
Today's Sponsor